Home/Filings/4/0000899243-23-004355
4//SEC Filing

DiPietro Kenneth 4

Accession 0000899243-23-004355

CIK 0001805387other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:25 PM ET

Size

12.8 KB

Accession

0000899243-23-004355

Insider Transaction Report

Form 4
Period: 2023-02-06
DiPietro Kenneth
Chief Human Resources Officer
Transactions
  • Award

    Restricted Stock Units

    2023-02-06+13,91313,913 total
    Common Stock (13,913 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-02-06+54,74954,749 total
    Exercise: $34.41Exp: 2033-02-06Common Stock (54,749 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on February 6, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
  • [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
  • [F3]The RSUs vest in four equal annual installments on each of February 6, 2024, February 6, 2025, February 6, 2026 and February 6, 2027, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Cerevel Therapeutics Holdings, Inc.

CIK 0001805387

Entity typeother

Related Parties

1
  • filerCIK 0001540188

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:25 PM ET
Size
12.8 KB